Furthermore, miR-210 overexpression inhibits pancreatic cancer growth and reverses gemcitabine resistance by directly targeting the multi-drug efflux transporter ABCC5, a crucial factor in drug resistance in various cancers [163]. This evidence concerns the gene ABCC5 and familial pancreatic carcinoma.